Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
CC transcript
Acq. announced

ALASKA AIR GROUP, INC. (ALK) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/25/2019 GN New Research: Key Drivers of Growth for Coty, Discovery, California Resources, Alaska Air Group, PPG Industries, and EPR Properties — Factors of Influence, Major Initiatives and Sustained Production
02/28/2019 GN Research Report Identifies Chico's FAS, Canadian National Railway, Alaska Air Group, Avnet, Taubman Centers, and MicroStrategy with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
01/28/2019 GN Report: Developing Opportunities within ONEOK, Alaska Air Group, Comcast, Mack-Cali Realty, Vistra Energy, and Xencor — Future Expectations, Projections Moving into 2019
12/18/2018 GN Alaska Expands Partnership With Points To Let Mileage Plan Members Redeem Miles For Elite Status
10/11/2018 GN New Research: Key Drivers of Growth for Procter & Gamble, Alaska Air Group, Leggett & Platt, Chase, MetLife, and American Assets Trust — Factors of Influence, Major Initiatives and Sustained Production
08/08/2018 GN Recent Analysis Shows Washington Real Estate Investment Trust, FirstEnergy, Alexion Pharmaceuticals, Alaska Air Group, Fortune Brands Home & Security, and Baxter International Market Influences — Renewed Outlook, Key Drivers of Growth
03/12/2018 GN Annual General Meeting in ALK-Abelló A/S held on 12 March 2018
03/12/2018 GN Generalforsamling i ALK-Abelló A/S afholdt den 12. marts 2018
03/02/2018 GN Indberetning af ledelsens transaktioner med ALK-Abelló A/S' B-aktier og tilknyttede værdipapirer
03/02/2018 GN Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
02/21/2018 GN New medicine for house dust mite allergic rhinitis and allergic asthma now available in France
02/16/2018 GN ALK's partner, Torii, gains paediatric approval for the house dust mite SLIT-tablet in Japan
02/16/2018 GN ALKs partner, Torii, opnår godkendelse af tabletvaccinen mod husstøvmideallergi til børn i Japan
02/06/2018 GN ALK releases its annual report 2017
02/06/2018 GN ALK offentliggør årsrapport for 2017
01/30/2018 GN Dato for offentliggørelse af årsrapport for 2017 for ALK og webcast
01/30/2018 GN Release date of annual report 2017 and audio cast
12/20/2017 GN ALK – Finanskalender for regnskabsåret 2018
12/20/2017 GN ALK – Financial calendar for the 2018 financial year
12/11/2017 GN Indberetning af transaktioner med ALK-Abelló A/S' B-aktier og tilknyttede værdipapirer udført af personer med nær tilknytning til personer med ledelsesansvar
12/11/2017 GN Reporting of transactions with ALK-Abelló A/S' B-shares and associated securities by person closely associated with person discharging managerial responsibly
12/11/2017 GN REGISTRERING AF KAPITALFORHØJELSE PÅ DKK 92.076 AA-AKTIER OG DKK 920.760 B-AKTIER VED UDSTEDELSE AF NYE AKTIER GENNEMFØRT
12/11/2017 GN REGISTRATION OF CAPITAL INCREASE OF DKK 92,076 AA SHARES AND DKK 920,760 B SHARES BY THE ISSUE OF NEW SHARES COMPLETED
12/07/2017 GN Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
12/07/2017 GN Indberetning af ledelsens transaktioner med ALK-Abelló A/S' B-aktier og tilknyttede værdipapirer
12/07/2017 GN PRISSÆTNING OG GENNEMFØRELSE AF UDBUD AF NYE AKTIER I ALK-ABELLÓ A/S
12/07/2017 GN PRICING AND FURTHER DETAILS ON THE OFFERING OF NEW SHARES IN ALK-ABELLÓ A/S
12/06/2017 GN ALK-ABELLÓ A/S TO ISSUE UP TO 92,076 AA SHARES AND UP TO 920,760 B SHARES IN A PRIVATE PLACEMENT
12/06/2017 GN UDSTEDELSE AF OP TIL 92.076 AA-AKTIER OG OP TIL 920.760 B-AKTIER I FORBINDELSE MED EN RETTET EMISSION I ALK-ABELLÓ A/S
12/05/2017 GN Detailed Research: Economic Perspectives on PPG Industries, Alaska Air Group, 3D, Washington Federal, Prosperity Bancshares, and BancorpSouth — What Drives Growth in Today's Competitive Landscape
12/04/2017 GN ALK launches ambitious, transformational growth strategy
12/04/2017 GN ALK præsenterer ambitiøs, transformerende vækststrategi
11/30/2017 GN ALK secures pricing and reimbursement for ACARIZAX® in France
11/30/2017 GN ALK opnår pris og tilskud for ACARIZAX® i Frankrig
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy